Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$176,816
+$7,448 QoQ
Shares Held
1,376
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#3,530
of 3,769 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OBSIDIAN CIO, LLC holds $12,058,485 across 9 Drug Manufacturers - General names. MRK ranks #6 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
18,327 | $6,636,573 | |
| 2 | NVO |
Novo Nordisk A S
|
73,106 | $3,504,701 | |
| 3 | ABBV |
AbbVie Inc.
|
2,391 | $601,671 | |
| 4 | JNJ |
Johnson & Johnson
|
2,245 | $570,162 | |
| 5 | LLY |
ELI LILLY & Co
|
436 | $522,951 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
1,376 | $176,816 | |
| 7 | PFE |
Pfizer Inc
|
1,249 | $30,075 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
102 | $12,886 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,816 | 1,376 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $169,368 | 1,408 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,473 | 52 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $236,934 | 2,823 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $229,009 | 2,893 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $275,742 | 3,072 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $251,584 | 2,529 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $244,154 | 2,150 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $277,683 | 2,243 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $220,488 | 1,671 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||